26.09.2022:
In 2020, more than 180,000 people in Norway used a selective serotonin reuptake inhibitor (SSRI), and the majority of these used escitalopram (1). SSRI drugs work by inhibiting the reuptake of serotonin in serotonergic synaptic clefts and entail a lower risk of toxic reactions and adverse effects...